RESPIRATORY
Chronic respiratory diseases are a set of conditions that affect different parts of the respiratory system, such as the bronchi, lungs, and chest cavity.
These diseases pose a significant challenge in Europe, being one of the leading causes of mortality and morbidity in the region. Every year, Europeans face a considerable financial cost, estimated at 102 million euros, due to these diseases.
Furthermore, in 2020, it is projected that approximately 11.9 million deaths worldwide will be attributed to respiratory diseases, underscoring the importance of addressing and preventing these conditions adequately.
Chronic respiratory diseases encompass a wide range of disorders, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and pneumonia, among others. These conditions can have a significant impact on people’s quality of life, limiting their ability to perform daily activities and affecting their overall well-being.
RESEARCH ON RESPIRATORY DISEASES
To effectively address respiratory diseases, it is essential to implement strategies for prevention, early detection, and proper treatment. This includes promoting healthy lifestyles, such as avoiding smoking and exposure to toxic substances, as well as ensuring equitable access to quality healthcare services and innovative treatments. Research and the development of new therapeutic approaches, along with strengthening education and awareness about respiratory diseases, are key elements in reducing the burden of these diseases in society. By working together, healthcare professionals, researchers, health authorities, and the pharmaceutical industry can contribute to improving the prevention, diagnosis, and treatment of respiratory diseases, allowing for a better quality of life for those affected.
THE ROLE OF PHARMACEUTICAL COMPANIES IN RESPIRATORY DISEASES
Pharmaceutical companies play a crucial role in the fight against respiratory diseases, offering innovative solutions and effective therapies to improve the quality of life for people affected by these conditions. Their commitment and dedication to the development of advanced respiratory treatments are key to addressing medical challenges and improving health outcomes in this area.
Pharmaceutical companies invest in research and development to discover new drugs and therapies that address the various aspects of respiratory diseases. They work in collaboration with scientists, doctors, and experts in the field of pulmonology to better understand the pathophysiology of these diseases and develop effective medications that alleviate symptoms, reduce disease progression, and enhance the quality of life for patients.
SUCCESS STORIES
- Asthma: Launch of a new indication in Asthma with a leading global molecule device
- Allergy:
- Spain: Omnichannel promotion since 2014 of medication for allergic rhinitis
-
Mexico: Omnichannel promotion of a family of medications for allergic rinitis and urticaria
- COPD: Omnichannel launch of a leading triple combination in previously uncovered states
BE PART OF OUR TEAM
WORK WITH US
We are an innovative laboratory that adds value to patients through the marketing of high-quality and trusted medications.
If you are passionate about this field and are looking to be part of a team committed to excellence, we invite you to join us.
AVANZIA PHARMA
CONTACT US